BamSEC and AlphaSense Join Forces
Learn More

Nanomix Corp

Formerly OTC: NNMX
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.27
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.28
from S-1/A 20 pages Warrant to Purchase Shares Common Stock of Nanomix, Inc. Dated as of [ ], 2020 Void After the Date Specified in Section 8
12/34/56
EX-4.27
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 15 pages Common Stock Purchase Warrant Nanomix Corporation
12/34/56
EX-4.2
from 8-K 27 pages Nanomix Corporation Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 49 pages Nanomix Corporation Senior Secured Convertible Note
12/34/56
EX-4.2
from 8-K 33 pages Boston Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 53 pages Boston Therapeutics, Inc. Senior Secured Convertible Note
12/34/56
EX-4.1
from 8-K 6 pages Secured Promissory Note
12/34/56
EX-4.1
from 8-K 13 pages Certificate of Designations, Preferences and Rights of the Series B Convertible Preferred Stock of Boston Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 2 pages Boston Therapeutics, Inc. Promissory Note
12/34/56
EX-4.3
from 8-K 10 pages Common Stock Purchase Warrant to Purchase [*] Shares of Common Stock of Boston Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 9 pages Certificate of Designation of Preferences, Rights and Limitations of Series a Preferred Stock of Boston Therapeutics, Inc. Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-4.1
from 8-K 16 pages Securities Purchase Agreement
12/34/56
EX-4.3
from 8-K 6 pages Boston Therapeutics, Inc. Stock Purchase Warrant
12/34/56
EX-4.2
from 8-K 21 pages 6% Subordinated Convertible Debenture Due 2018
12/34/56
EX-4.1
from 8-K 11 pages Boston Therapeutics, Inc. Securities Purchase Agreement
12/34/56
EX-4.4
from 10-Q 3 pages August 12, 2016 Cjy Holdings Limited 12 Repulse Bay Road Repulse Bay, Hong Kong Re: 10% Convertible Promissory Notes Issued to Cjy Holdings Limited by Boston Therapeutics Inc. in the Aggregate Principal Amount of $1,702,000 (The "Notes") Gentlemen: Reference Is Hereby Made to the Notes. All Terms Not Defined Below Shall Have the Meaning as Set Forth in the Notes. by Executing This Letter, the Undersigned Parties Hereby Agree That the Notes Shall Be Amended and Restated to Provide for a Maturity Date of August 12, 2018. in Addition, the Undersigned Parties Hereby Agree That the Notes Shall Be Amended and Restated to Add Article 2(a)(ii)(d) as Follows
12/34/56
EX-4.3
from 10-Q 10 pages Boston Therapeutics, Inc. Stock Purchase Warrant
12/34/56
EX-4.2
from 10-Q 30 pages 6% Senior Convertible Debenture Due 2018
12/34/56